Major Histocompatibility Complex

Listeriolysin O 190 peptide

SIITFEKL, OVA (257-264) Variant

Calnexin; IP90; Major Histocompatibility Complex Class I Antigen-Binding Protein p88; CANX

rHuCalnexin, His; Calnexin; IP90; Major Histocompatibility Complex Class I Antigen-Binding Protein p88; CANX

B2 microglobulin; DADB-15K14.8; HLA 6.0; HLA class I Histocompatibility antigen alpha chain G; Major Histocompatibility Complex class I G; MHC class I antigen; MHC class I antigen G; MHC G; T-cell A locus; TCA

MR1 & B2M; Major Histocompatibility Complex class I-related protein 1; MR1; MHC class I-related protein 1; Class I Histocompatibility antigen-like protein; MR1

B2 microglobulin; DADB-15K14.8; HLA 6.0; HLA class I Histocompatibility antigen alpha chain G; HLA class I Histocompatibility antigen; alpha chain G; HLA class I molecule; HLA G; HLA G antigen; HLA G Histocompatibility antigen class I G; HLA G3; HLA-G; HLA-G Histocompatibility antigen; class I; HLA60; HLAG; HLAG_HUMAN; Major Histocompatibility Complex class I G; MHC class I antigen; MHC class I antigen G; MHC G; T-cell A locus; TCA

CANX; Calnexin; IP90; Major Histocompatibility Complex class I antigen-binding protein p88; p90

NF-kappa-B inhibitor alpha; I-kappa-B-alpha; IkB-alpha; IkappaBalpha; Major Histocompatibility Complex enhancer-binding protein MAD3;

NFKBIA; IKBA; MAD3; NFKBI; NF-kappa-B inhibitor alpha; I-kappa-B-alpha; IkB-alpha; IkappaBalpha; Major Histocompatibility Complex enhancer-binding protein MAD3

NFKBIA; IKBA; MAD3; NFKBI; NF-kappa-B inhibitor alpha; I-kappa-B-alpha; IkB-alpha; IkappaBalpha; Major Histocompatibility Complex enhancer-binding protein MAD3

NFKBIA; IKBA; MAD3; NFKBI; NF-kappa-B inhibitor alpha; I-kappa-B-alpha; IkB-alpha; IkappaBalpha; Major Histocompatibility Complex enhancer-binding protein MAD3

CANX; Calnexin; IP90; Major Histocompatibility Complex class I antigen-binding protein p88; p90

CANX; Calnexin; IP90; Major Histocompatibility Complex class I antigen-binding protein p88; p90

DASS-397D15.1 antibody; DR alpha chain antibody; DR alpha chain precursor antibody; DRA_HUMAN antibody; DRB1 antibody; DRB4 antibody; FLJ51114 antibody; Histocompatibility antigen HLA DR alpha antibody; Histocompatibility antigen HLA-DR alpha antibody; HLA class II Histocompatibility antigen antibody; HLA class II Histocompatibility antigen DR alpha chain antibody; HLA DR1B antibody; HLA DR3B antibody; HLA DRA antibody; HLA DRA1 antibody; HLA DRB1 antibody; HLA DRB3 antibody; HLA DRB4 antibody; HLA DRB5 antibody; HLA-DR Histocompatibility type antibody; HLA-DRA antibody; HLADR4B antibody; HLADRA1 antibody; HLADRB antibody; Major Histocompatibility Complex class II DR alpha antibody; Major Histocompatibility Complex class II DR beta 1 antibody; Major Histocompatibility Complex class II DR beta 3 antibody; Major Histocompatibility Complex class II DR beta 4 antibody; Major Histocompatibility Complex class II DR beta 5 antibody; MGC117330 antibody; MHC cell surface glycoprotein antibody; MHC class II antigen DRA antibody; MHC II antibody; MLRW antibody; OTTHUMP00000029406 antibody; OTTHUMP00000029407 antibody; HLA-DRA nanobody;

CD 74 antibody; CD74 antibody; CD74 antigen; invariant polypeptide of Major Histocompatibility Complex; class II antigen-associated; antibody; CD74 antigen antibody; CD74 molecule antibody; CD74 molecule; Major Histocompatibility Complex; class II invariant chain antibody; CLIP antibody; DHLAG antibody; Gamma chain of class II antigens antibody; HG2A_HUMAN antibody; HLA class II Histocompatibility antigen gamma chain antibody; HLA DR antigens associated invariant chain antibody; HLA DR gamma antibody; HLA-DR antigens-associated invariant chain antibody; HLA-DR-gamma antibody; HLADG antibody; HLADR antigens associated invariant chain antibody; Ia antigen associated invariant chain antibody; Ia antigen-associated invariant chain antibody; Ia associated invariant chain antibody; Ia gamma antibody; Ii antibody; Invariant polypeptide of Major Histocompatibility Complex class II antigen associated antibody; la-gamma antibody; Major Histocompatibility Complex class II invariant chain antibody; MHC HLA DR gamma chain antibody; MHC HLA-DR gamma chain antibody; p33 antibody; p35 antibody; Protein 41 antibody;

class II antigen HLA-DM beta chain antibody; class II Histocompatibility antigen antibody; Class II Histocompatibility antigen M beta chain antibody; D6S221E antibody; DMB antibody; HLA class II Histocompatibility antigen DM beta chain antibody; HLA-DM Histocompatibility type, beta chain antibody; M beta chain antibody; Major Histocompatibility Complex class II DM beta antibody; MHC class II antigen DMB antibody; class II antigen HLA-DM beta chain antibody; class II Histocompatibility antigen antibody; Class II Histocompatibility antigen M beta chain antibody; D6S221E antibody; DMB antibody; HLA class II Histocompatibility antigen DM beta chain antibody; HLA-DM Histocompatibility type, beta chain antibody; M beta chain antibody; Major Histocompatibility Complex class II DM beta antibody; MHC class II antigen DMB antibody; MHC class II antigen HLA DM beta chain antibody; MHC class II HLA DMB antibody; OTTHUMP00000029257 antibody; Really interesting new gene 7 protein antibody; RING 7 antibody; RING7 antibody;

HLA DPA1; Major Histocompatibility Complex; class II; DP alpha 1; PLT1; HLADP; HLASB; DP(W3); DP(W4); HLA-DP1A

Antigen Presenting Molecule antibody; Cw*1701 antibody; D6S204 antibody; FLJ27082 antibody; HLA A antibody; HLA B antibody; HLA C antibody; HLA class 1 A antibody; HLA class 1 B antibody; HLA class 1 C antibody; HLA JY3 antibody; HLAA antibody; HLAB antibody; HLAC antibody; HLC C antibody; Human Leucocyte Antigen C antibody; Major Histocompatibility Complex Class I A antibody; Major Histocompatibility Complex Class I B antibody; Major Histocompatibility Complex Class I C antibody; Major Histocompatibility Complex, class I, A + B + C antibody; MHC class I antigen A*1 antibody; MHC Class I Antigen antibody; MHC class I antigen B*7 antibody; MHC class I antigen Cw*1 antibody; MHC class I HLA A antibody; MHC class I HLA B antibody; MHC class I HLA C antibody; MHC HLA ABC antibody; PSORS1 antibody

HLA class I Histocompatibility antigen E alpha chain antibody; EA1.2 antibody; EA2.1 antibody; HLA 6.2 antibody; HLA class I Histocompatibility antigen alpha chain E antibody; HLA class I Histocompatibility antigen E alpha chain precursor antibody; HLA class I Histocompatibility antigen E alpha chain precursor antibody; HLA6.2 antibody; HLAE antibody; Lymphocyte antigen antibody; Major Histocompatibility Complex class I E antibody; MHC antibody; MHC class I antigen E antibody; MHC HLA E alpha 1 antibody; MHC HLA E alpha 2.1 antibody; QA1 antibody;

I kappa B alpha antibody; I-kappa-B-alpha antibody; IkappaBalpha antibody; IkB-alpha antibody; IKBA antibody; IKBA_HUMAN antibody; IKBalpha antibody; MAD 3 antibody; MAD3 antibody; Major Histocompatibility Complex enhancer-binding protein MAD3 antibody; I kappa B alpha antibody; I-kappa-B-alpha antibody; IkappaBalpha antibody; IkB-alpha antibody; IKBA antibody; IKBA_HUMAN antibody; IKBalpha antibody; MAD 3 antibody; MAD3 antibody; Major Histocompatibility Complex enhancer-binding protein MAD3 antibody; NF kappa B inhibitor alpha antibody; NF-kappa-B inhibitor alpha antibody; NFKBI antibody; NFKBIA antibody; Nuclear factor of kappa light chain gene enhancer in B cells antibody; Nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor alpha antibody;